黴漿菌檢測市場規模、佔有率、成長分析，按產品/服務、按方法、按應用、按最終用戶、按地區 - 行業預測，2024-2031

2022年全球黴漿菌檢測市場規模將為8.296億美元，從2023年的91.1023億美元成長到2031年的19.1178億美元，並將在預測期內成長（2024-2024年），預計複合年成長率為9.72 % 2031）。

黴漿菌檢測市場旨在為各領域檢測和預防黴漿菌污染提供可靠、準確、高效的工具和服務。市場包括套件、試劑、儀器和軟體等各種產品，以及測試、檢驗和諮詢等化驗服務。主要市場促進因素包括對生物製藥和細胞療法的需求不斷成長、對黴漿菌污染風險的認知不斷提高以及測試技術的進步。嚴格的監管要求進一步推動了對強大檢測解決方案的需求。然而，檢測成本高、檢測方法缺乏標準化、熟練勞動力缺乏等挑戰阻礙了市場的發展。進一步的挑戰包括需要持續創新、解決虛假結果和交叉反應等問題，以及適應不斷變化的需求。成長機會包括開拓新技術、開拓新的地區和產業、將檢驗與其他品管系統結合、利用數位化和自動化趨勢來提高效率和準確性。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 價值鏈分析
• 供應鏈分析

黴漿菌檢測市場：依產品/服務分類

• 市場概況
• 測定、套件和試劑
  • NAT 測定、套件和試劑
  • 酵素結合免疫吸附測定、套件及試劑
  • 拆卸套件
  • 染色
  • 其他測定、套件及試劑
• 裝置
• 服務

黴漿菌檢測市場：依方法分類

• 市場概況
• 核酸檢測
• 酵素免疫分析法
• 染色
• 其他技術

黴漿菌檢測市場：依應用分類

• 市場概況
• 細胞株測試
• 病毒測試
• 生產結束時進行電池測試

黴漿菌測試市場：依最終用戶分類

• 市場概況
• 製藥和生物技術公司
• 藥品委外研發機構
• 學術/研究機構
• 細胞庫/實驗室

黴漿菌檢測市場規模：依地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Merck KGaA
• Roche Diagnostics（A Division of F. Hoffmann-La Roche Ltd.）
• Charles River Laboratories International, Inc.
• Lonza Group Ltd.
• Thermo Fisher Scientific, Inc.
• Eurofins Scientific Group
• Sartorius Stedim Biotech SA
• Agilent Technologies, Inc.
• Meridian Bioscience, Inc.
• American Type Culture Collection
• Bionique Testing Laboratories, Inc.
• InvivoGen
• PromoCell GmbH
• Biological Industries Israel Beit Haemek Ltd.
• Clongen Laboratories, LLC
• Creative Bioarray
• Nelson Laboratories Fairfield, Inc.（A Part of Sotera Health）
• Norgen Biotek Corporation
• Biotools B & M Labs, SA
• GenBio（A Part of ExonHit Therapeutics SA）
• GeneCopoeia, Inc.
• Minerva Biolabs GmbH
• Mycoplasma Experience
• Savyon Diagnostics
• ScienceCell Research Laboratories

Global Mycoplasma Testing Market size was valued at USD 829.6 million in 2022 and is poised to grow from USD 9110.23 million in 2023 to USD 1911.78 million by 2031, growing at a CAGR of 9.72% during the forecast period (2024-2031).

The mycoplasma testing market aims to deliver reliable, accurate, and efficient tools and services for detecting and preventing Mycoplasma contamination across various sectors. It includes a range of products such as kits, reagents, instruments, and software, alongside laboratory services like testing, validation, and consulting. Key drivers of the market include the rising demand for biopharmaceuticals and cell-based therapies, heightened awareness of mycoplasma contamination risks, and advancements in testing technologies. Stringent regulatory requirements further propel the need for robust testing solutions. However, challenges such as high testing costs, a lack of standardized methods, and limited skilled personnel hinder the market. Additionally, the need for continuous innovation, addressing issues like false results and cross-reactivity, and adapting to evolving demands pose significant challenges. Opportunities for growth include the development of new technologies, market expansion into new regions and industries, and integrating testing with other quality control systems, while leveraging trends in digitization and automation to improve efficiency and accuracy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mycoplasma Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mycoplasma Testing Market Segmental Analysis

Global Mycoplasma Testing Market is segmented by Product & Service, Technique, Application, End User, and Region. Based on Product & Service, the market is segmented into Assays, Kits, & Reagents (NAT Assays, Kits, & Reagents; Enzyme-Linked Immunosorbent Assays, Kits, & Reagents, Elimination Kits, Stains, Other Assays, Kits, & Reagents), Instruments, Services. Based on Technique, the market is segmented into Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay, Staining, Other Techniques. Based on Application, the market is segmented into Cell Line Testing, Virus Testing, End-Of-Production Cell Testing. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes, Cell Banks & Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Drivers of the Global Mycoplasma Testing Market

As awareness of the risks and consequences associated with Mycoplasma contamination grows, so does the demand for Mycoplasma testing. Contamination can significantly impact experimental results, affecting the reliability of research findings and altering cellular behavior. Additionally, it poses health risks to researchers and patients, further underscoring the need for effective testing solutions to ensure accuracy and safety in various scientific and clinical settings.

Restraints in the Global Mycoplasma Testing Market

The high expense associated with mycoplasma testing products and services can pose a considerable obstacle for many customers, particularly in emerging markets or resource-limited environments. Costs can fluctuate based on the type of test, the complexity of the sample, and the test's sensitivity and specificity. Advanced methods, such as PCR-based assays or high-throughput sequencing, are especially costly and may be out of reach for some customers, further limiting accessibility.

Market Trends of the Global Mycoplasma Testing Market

The integration of Mycoplasma testing with other quality control and assurance systems, such as microbial identification, endotoxin testing, and bioburden testing, is increasingly common in the market. This trend enables customers to consolidate their testing processes, leading to more efficient workflows. By combining these tests, customers can achieve faster turnaround times and reduce overall testing costs, enhancing both operational efficiency and cost-effectiveness.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Supply Chain Analysis

Mycoplasma Testing Market, By Product & Service

• Market Overview
• Assays, Kits, & Reagents
  • NAT Assays, Kits, & Reagents
  • Enzyme-Linked Immunosorbent Assays, Kits, & Reagents
  • Elimination Kits
  • Stains
  • Other Assays, Kits, & Reagents
• Instruments
• Services

Mycoplasma Testing Market, By Technique

• Market Overview
• Nucleic Acid Testing
• Enzyme-Linked Immunosorbent Assay
• Staining
• Other Techniques

Mycoplasma Testing Market, By Application

• Market Overview
• Cell Line Testing
• Virus Testing
• End-Of-Production Cell Testing

Mycoplasma Testing Market, By End User

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic & Research Institutes
• Cell Banks & Laboratories

Mycoplasma Testing Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius Stedim Biotech S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Type Culture Collection
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionique Testing Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InvivoGen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological Industries Israel Beit Haemek Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clongen Laboratories, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Bioarray
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nelson Laboratories Fairfield, Inc. (A Part of Sotera Health)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norgen Biotek Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotools B & M Labs, S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenBio (A Part of ExonHit Therapeutics SA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneCopoeia, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Minerva Biolabs GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mycoplasma Experience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Savyon Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScienceCell Research Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments